ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $33,739 | +84247.5% | 10,193 | 0.0% | 0.00% | – |
| Q4 2022 | $40 | -99.8% | 10,193 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $25,000 | +25.0% | 10,193 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $20,000 | +5.3% | 10,193 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $19,000 | +35.7% | 10,193 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +16.7% | 10,193 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | -40.0% | 10,193 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $20,000 | – | 10,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |